Browse and enroll in any of our External Quality Assessment schemes—choose from genomic, technical, prenatal, and more. Participating in an EQA ensures your lab's results meet international standards and helps you achieve accreditation. Select a category or apply filters to narrow down the schemes relevant to your laboratory.
Individual competency assessment for classification of BRCA1, BRCA2 and HRR gene variants. Two runs per year in collaboration with GenQA. See https://genqa.org/BRCA-HRR for registration details.
Panel testing for Cardiac disorders (targeted NGS/ virtual panel /clinical exome / WES / WGS). This EQA has options for Arrythmia panel, Hypertrophic Cardiomyopathy panel, and all Cardiac Disorders.
EQA for quality and quantity of cfDNA extracted from plasma. There are two rounds of EQA per year which need to be purchased separately. This EQA will be distributed in March 2026.
EQA for quality and quantity of cfDNA extracted from plasma. There are two rounds of EQA per year which need to be purchased separately. This EQA will be distributed in Sept 2026.
Charcot-Marie-Tooth disease / Hereditary Neuropathy with liability for Pressure Palsies (CMT/HNPP)
Product Code: 01-CMT-26
From £515.00
Registration closed: 30/11/2025
PMP22 deletion/duplication testing for CMT/HNPP, this EQA has options for PMP22 targeted testing and panel testing for CMT/HNPP associated genes (Germline DNA).
Identification of different types of variants and genomic signatures by CGP in solid tumour (FFPE). This is a pilot EQA (genotyping only), places are limited, complete the form to express interest in participation (see participant information section).
CFTR testing for Cystic Fibrosis (germline DNA testing). To participate in EQA for Cystic Fibrosis, please go to our partner organisation’s (CF Network) website (https://eqascheme.org)
Device verification samples for CYP2C19 (POCT) – 1 SET
Product Code: 07-DVS-CYP2C19X01-26
From £890.00
Deadline to order: N/A
One set of 8 patient-like swab-based materials designed to help implement and verify POCT devices for CYP2C19 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for CYP2C19 (POCT) – 2 SETS
Product Code: 07-DVS-CYP2C19X02-26
From £1,155.00
Deadline to order: N/A
Two sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for CYP2C19 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for CYP2C19 (POCT) – 3 SETS
Product Code: 07-DVS-CYP2C19X03-26
From £1420.00
Deadline to order: N/A
Three sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for CYP2C19 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for CYP2C19 (POCT) – 4 SETS
Product Code: 07-DVS-CYP2C19X04-26
From £1690.00
Deadline to order: N/A
Four sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for CYP2C19 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for CYP2C19 (POCT) – 5 SETS
Product Code: 07-DVS-CYP2C19X05-26
From £1955.00
Deadline to order: N/A
Five sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for CYP2C19 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for MT-RNR1 (POCT) – 1 SET
Product Code: 07-DVS-MTRNR1X01-26
From £890.00
Deadline to order: N/A
One set of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for MT-RNR1 (POCT) – 2 SET
Product Code: 07-DVS-MTRNR1X02-26
From £1,155.00
Deadline to order: N/A
Two sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for MT-RNR1 (POCT) – 3 SET
Product Code: 07-DVS-MTRNR1X03-26
From £1420.00
Deadline to order: N/A
Three sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for MT-RNR1 (POCT) – 4 SET
Product Code: 07-DVS-MTRNR1X04-26
From £1690.00
Deadline to order: N/A
Four sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Device verification samples for MT-RNR1 (POCT) – 5 SET
Product Code: 07-DVS-MTRNR1X05-26
From £1955.00
Deadline to order: N/A
Five sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for MT-RNR1 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
PKD1 / PKD2 and panel testing for patients with Hereditary Cystic Kidney Disease. This EQA has options for targeted testing and panel testing (germline DNA testing).
Testing for Hereditary Renal / Kidney Cancer. This EQA has options for targeted VHL testing or gene panel testing of hereditary renal cancer disorders (Germline DNA)
Panel testing for isolated and syndromic Inherited Retinal Disorders (IRD) (Germline DNA). Includes one case involving a gene related to an approved/in trial therapy, and option for RPGR ORF15 testing.
This EQA has two modules: COMMON BIOMARKERS (mandatory to participate in this EQA) and NEW & EMERGING BIOMARKERS (optional to participate in this EQA) both using FFPE to test.
The New and Emerging Biomarkers EQA Scheme (02-LUNGT-NEWB-26) is available for purchase at £299.
Testing for variants in the mitochondrial genome for the following mitochondrial disorders: MELAS, NARP, LHON, MERRF, Leigh syndrome, and Pearson syndrome.
EQA for quality of NGS for SNVs and indels <50bp (Germline DNA). For any NGS strategy (single gene, panel testing, whole exome sequencing or whole genome sequencing).
NGS for somatic SNVs and indels – tumour testing only
Product Code: 03-NGSS-SNV-26
From £745.00
Registration closed: 31/03/2026
EQA for quality of NGS for somatic SNVs and indels <50bp (FFPE). For NGS NOT requiring a matched normal control germline sample (single gene, panel testing, whole exome sequencing or whole genome sequencing). Pilot EQA.
NGS for somatic SNVs and indels – tumour with germline subtraction analysis
Product Code: 03-NGSS-PLM-26
From £1159.00
Registration closed: 31/03/2026
EQA for quality of NGS for somatic SNVs and indels <50bp (FFPE). For NGS requiring a matched normal control germline sample (single gene, panel testing, whole exome sequencing or whole genome sequencing). Pilot EQA.
This EQA scheme is offered to help laboratories using high through put technologies (e.g., NGS, MassArray etc.) to accurately validate assay sensitivity and specificity. For specific tumour types, please register for the relevant scheme (e.g., Lung, Melanoma, Colorectal, Ovarian, Breast, Prostate, Pancreas). High quality reference materials are provided covering a range of genes with variants with ddPCR quantified allelic frequencies.
Ovarian, Breast, Prostate and Pancreatic Cancers (PARPi) [DNA, Germline]
Product Code: 02-PARPIG-26
From £450.00
Registration closed: 31/03/2026
BRCA1 and BRCA2 testing for Ovarian, Breast, prostate and pancreatic cancer (Germline DNA) in the context of PARP inhibitor prescription. This EQA is sponsored.
APC and MUTYH testing for patients with disorders associated with polyposis (Familial adenomatous polyposis (FAP) and MUTYH-associated polyposis (MAP)) and familial cases.
Molecular genetic testing for patients with porphyria and familial cases (group of eight disorders of the heme biosynthesis pathway, as defined by Ipnet).
Gene panel testing for patients affected with a form of skeletal dysplasia. This is a pilot EQA, places are limited, complete the form to express interest in participation (see participant information section).
